Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia-mediated phase transition.
Elastin-like polypeptides (ELPs) composed of a VPGXG repeat undergo a reversible phase transition in aqueous solution. They are hydrophilic and soluble in aqueous solution below their transition temperature (T(t)), but they become hydrophobic and aggregate when the temperature is raised above their T(t). In this study, we examine the quantitative uptake of a fluorescence-labeled, thermally responsive ELP as a function of ELP concentration between 5 and 15 microM in solution in response to hyperthermia by three cultured cancer cell lines. Flow cytometry of fluorescein-ELP conjugates showed that hyperthermia enhanced the cellular uptake of the thermally responsive ELP in human ovarian carcinoma cells (SKOV-3) and in HeLa cells at a concentration of 10 microM or higher, but not at a concentration of 5 microM, as compared with the uptake of a thermally inactive ELP control. In FaDu cells, hyperthermia stimulated uptake of the thermally responsive ELP at all solution concentrations of ELP between 5 and 15 microM. In particular, a >2-fold greater uptake of thermally responsive ELP compared with the thermally inactive control ELP was observed for FaDu cells at a solution concentration of 15 microM in heated cells. Confocal fluorescence microscopy of tumor cells incubated with a rhodamine conjugate of the thermally responsive ELP showed that the cytoplasm was uniformly stained below the T(t). Above the T(t), fluorescent particles were observed in the cytoplasm, suggesting that these particles are aggregates of the thermally responsive polypeptide resulting from the ELP phase transition. These studies demonstrate that the endocytotic uptake of a thermally responsive ELP is significantly enhanced by the thermally triggered phase transition of the polypeptide.
Raucher
D
D
Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708, USA.
Chilkoti
A
A
D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000628:therapy; D004337:Drug Carriers; D004549:Elastin / Q000737:chemistry / Q000493:pharmacokinetics*; D005260:Female; D005434:Flow Cytometry; D005456:Fluorescent Dyes; D006358:Hot Temperature; D006801:Humans; D006979:Hyperthermia, Induced; D007700:Kinetics; D018613:Microscopy, Confocal; D010051:Ovarian Neoplasms / Q000378:metabolism* / Q000628:therapy; D010455:Peptides / Q000737:chemistry / Q000493:pharmacokinetics*; D013347:Subcellular Fractions / Q000378:metabolism; D014407:Tumor Cells, Cultured
D004337:Drug Carriers; D005456:Fluorescent Dyes; D010455:Peptides; D004549:Elastin